• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Significant number of patients being treated with aspirin in addition to direct oral anticoagulant without clear indication

byJack LennonandAlex Chan
May 17, 2021
in Cardiology, Chronic Disease
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Roughly 33.8% of patients with atrial fibrillation and/or venous thromboembolism undergoing treatment with a direct oral anticoagulant (DOAC) were also being treated with aspirin without a clear indication.

2. Patients being treated with DOAC and aspirin experienced significantly more bleeding events and hospitalizations, compared to DOAC monotherapy.

Evidence Rating Level: 2 (Good)

Study Rundown: The number of patients with atrial fibrillation (AF) or venous thromboembolism (VTE) taking acetylsalicylic acid (ASA) in combination with a direct oral anticoagulant (DOAC) is unclear. However, the frequency of this pharmacological combination is worth exploring to determine the risks associated with ASA use when combined with DOAC, and whether or not these risks are clinically warranted.

This registry-based cohort study of patients with AF or VTE, undergoing DOAC treatment, used data from four anticoagulation clinics in Michigan, U.S. between January 2015 and December 2019. Roughly 33% of patients were being treated with DOAC and ASA without a clear indication. This combination, compared to DOAC monotherapy, was associated with increased bleeding and hospitalizations.

Overall, this study found that, among patients with AF and/or VTE being treated with a DOAC, over one-third was also being treated with ASA without a clear indication. With increased rates of bleeding events and hospitalizations among the DOAC+ASA group, compared to DOAC monotherapy, it is important to recognize the risks associated with adding ASA among this patient population and weigh the potential benefits of straying from DOAC monotherapy.

Click to read the study in JAMA Internal Medicine

RELATED REPORTS

2 Minute Medicine Rewind April 25, 2022

Reduced bleeding risk with asundexian compared to apixaban in patients with atrial fibrillation

2 Minute Medicine Rewind April 11, 2022

Relevant Reading: Comparative Effectiveness of Direct Oral Anticoagulants and Warfarin in Patients With Cancer and Atrial Fibrillation

In-Depth [ retrospective cohort]:

It is unclear the degree to which ASA (or aspirin) is prescribed in combination with a DOAC for patients with AF or VTE. Further, it is possible that the addition of ASA may increase bleeding and hospitalization risk among patients with AF and/or VTE. This registry-based cohort study investigated the frequency of this pharmacological combination and the outcomes associated with it, compared to DOAC monotherapy. Main outcomes were bleeding, emergency department visits, hospitalizations, rates of thrombosis, and death.

A total of 3,280 patients (M [SD] age = 68.2 [13.3] years, 49.0% female) were included from four clinics in Michigan, U.S. Approximately 33.8% of these patients, each with AF and/or VTE and no recent history of myocardial infarction or heart valve replacement, were being treated with DOACs and ASA without a clear indication for ASA.   Two propensity score-matched cohorts of 1,047 patients were further analyzed to determine differences in risks and outcomes among DOAC+ASA and DOAC monotherapy, with a mean (SD) follow-up of 20.9 (19.0) months. Patients in the DOAC+ASA group experienced significantly more bleeding events compared to the DOAC monotherapy group (difference 5.6 bleeds per 100 patient years, p = .01). Differences were primarily with nonmajor bleeding (difference 4.4 bleeds per 100 patient years, p = .02), with major bleeding rates being similar between groups. Patients taking DOAC+ASA were also more often hospitalized, compared to the DOAC monotherapy group (p = .02). However, rates of thrombotic events were similar between groups (p = .80).

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: atrial fibrillationhematologythrombosis
Previous Post

Elevated systolic blood pressure is associated with left ventricular remodelling in adults born preterm

Next Post

Maternal weight gain and pregnancy outcomes in twin gestations

RelatedReports

Weekly Rewinds

2 Minute Medicine Rewind April 25, 2022

April 25, 2022
Stroke expansion following intra-arterial therapy may explain worse outcomes
Cardiology

Reduced bleeding risk with asundexian compared to apixaban in patients with atrial fibrillation

April 19, 2022
Compliance-linked incentives increase infant immunizations rates in rural India
Weekly Rewinds

2 Minute Medicine Rewind April 11, 2022

April 11, 2022
Evidence-based interventions for pediatric asthma successfully adapted for community health centers
Weekly Rewinds

2 Minute Medicine Rewind Feb 21, 2022

February 21, 2022
Next Post
Increased severe maternal morbidity with multiple gestation pregnancies

Maternal weight gain and pregnancy outcomes in twin gestations

Higher plasma levels of omega-3 fatty acids not associated with worse cardiovascular outcomes compared to corn oil placebo

Reinnervation of cardiac infarcts decreases subsequent arrhythmia incidence [PreClinical]

Carriers of truncated variants in filamin C with left ventricular systolic dysfunction associated with increased frequency of cardiac adverse events

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
  • #VisualAbstract: Ruxolitinib shows long-term safety and efficacy in inadequately controlled polycythaemia vera without splenomegaly
  • Wellness Check: Sleep
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.